Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
30 July 2010
IN THIS ISSUE
Sanofi fights approval
Servier under scrutiny
EC customs seizures
Outsourcing IT
 
Sanofi fights FDA approval of generic Lovenox
The FDA has approved the first generic version of the blockbuster low molecular weight heparin Lovenox (enoxaparin sodium), much to originator sanofi-aventis’s displeasure. More...
 
Servier under EC scrutiny for anticompetitive behavior
French pharma giant Les Laboratoires Servier SA has been accused of providing “misleading” and “incorrect” information during the EC’s antitrust investigation. More...
 
EC drug seizures in 2009
In 2009, the EC customs seized 11,462,533 medicines and medical products for suspected violations of intellectual property (IP), according to the Commission’s annual report on EU Customs Enforcement of Intellectual Property Rights. More...
 
Third-party outsourcing of IT services on the rise
A new report from the International Data Corporation (IDC) shows that life-science companies are increasingly using third-party outsourcing firms to augment or replace their information technology services. More...
 
Join our community on LinkedIn
Want to discuss any of this week’s news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...

Latest blog posts
J&J and guilt by association
B2B 2.0
China’s pharma market: friend or foe?
More blog posts

Latest peer-reviewed research
Capturing the advantages of co-crystals
A risk-management approach to cleaning-assay validation
Detecting GMP failures
More latest articles

Upcoming events
Charles Rivers Annual Biotech Symposium (13–15 September | USA)
DigiPharm Europe 2010 (28 September–1 October | UK)
Biobusiness Network (29–30 September | Switzerland)
More events

Podcast
Vetter
The North American market is critical to Vetter’s strategic global growth as nearly half of its client base is already located here. In order to maximize on this opportunity, Vetter has decided to create a facility, its first outside of Germany, at the Illinois Science + Technology Park in suburban Chicago.

Expansion of Vetter Development Service (VDS)


Survey
What is your opinion of the rising trend in the pharma industry to outsource functions to emerging countries?
It has many benefits   28%
I’d rather outsource closer to home   34%
I'd prefer to retain functions in-house   38%

This week we would like to know...

What is your main concern regarding the outsourcing of various services to emerging countries?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom